NCT06101680 (RYR) is a clinical trial in Rhabdomyolysis, sponsored by Central Hospital, Nancy, France.

Who is sponsoring NCT06101680?

NCT06101680 is sponsored by Central Hospital, Nancy, France.

What condition does NCT06101680 study?

NCT06101680 studies Rhabdomyolysis.

Is NCT06101680 still recruiting?

NCT06101680 is currently status unknown. Last updated 26 October 2023.

Last reviewed 2023-10-26 · How we verify

NCT06101680: RYR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

RhabdomYolyse in Intensive caRe

Status unknown Last updated 26 October 2023

What this trial tests

trial in Rhabdomyolysis in 200 participants. Status unknown.

Timeline

1 October 2023

Primary endpoint
1 December 2023

1 January 2024

Quick facts

Lead sponsor	Central Hospital, Nancy, France
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	1 October 2023
Primary completion	1 December 2023
Estimated completion	1 January 2024
Sites	1 location across France

Conditions studied

Rhabdomyolysis — all drugs for Rhabdomyolysis →

Sponsor

Central Hospital, Nancy, France

Who can join

Adults 0 to 18, any sex, with Rhabdomyolysis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Analysis of the outcome of patients \< 18 years old, treated in an intensive care unit for severe rhabdomyolysis, regardless of etiology (renal failure rate, death rate, organ replacement rate)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Rhabdomyolysis

Currently open trials in the same condition.

NCT06429982 — Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols · Phase 1 · recruiting
NCT07528300 — Effect of Battlefield Acupuncture on Pain Control During Inpatient Treatment of Exertional Rhabdomyolysis · NA · recruiting

Other Central Hospital, Nancy, France trials

Trials by the same sponsor.

NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06101680 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
Last refreshed: 26 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06101680.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing